NSE:GUFICBIO
Gufic Biosciences Limited
- Stock
Last Close
327.35
29/04 09:59
Market Cap
34.80B
Beta: 0.79
Volume Today
109.79K
Avg: 85.49K
PE Ratio
39.21
PFCF: -
Dividend Yield
0.03%
Payout:0%
Mar '14 | Mar '15 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
net income | 62.73M - | 65.26M 4.02% | 111.91M 71.49% | 180.17M 61.00% | 160.22M 11.08% | 219.41M 36.94% | 228.57M 4.17% | 442.32M 93.52% | 958.40M 116.68% | 797.05M 16.84% | |
depreciation and amortization | 24.68M - | 38.52M 56.10% | 37.87M 1.70% | 36.83M 2.73% | 43.02M 16.80% | 46.47M 8.01% | 83.50M 79.70% | 163.08M 95.30% | 171.34M 5.07% | 222.81M 30.04% | |
deferred income tax | |||||||||||
stock based compensation | |||||||||||
change in working capital | -1.88M - | -16.20M 760.03% | -213.15M 1,215.47% | -284.36M 33.41% | -300.59M 5.71% | -335.17M 11.51% | 70.64M 121.08% | 99.69M 41.11% | -102.02M 202.34% | -1.35B 1,225.80% | |
accounts receivables | -350.81M - | -167.18M 52.35% | -189.90M 13.59% | -231.93M 22.13% | -553.16M 138.50% | ||||||
inventory | -61.20M - | -106.86M 74.62% | -134.62M 25.98% | -127.53M 5.26% | -308.67M 142.03% | -836K 99.73% | -149.13M 17,738.64% | 280.57M 288.14% | -211.62M 175.43% | -678.91M 220.81% | |
accounts payables | 16.48M - | 274.23M 1,564.53% | 9.02M 96.71% | 341.54M 3,686.88% | -120.46M 135.27% | ||||||
other working capital | 59.31M - | 90.66M 52.85% | -78.53M 186.62% | -156.83M 99.71% | 8.08M 105.15% | -1K 100.01% | 112.72M 11,272,000% | -1K - | |||
other non cash items | 23.13M - | 23.95M 3.57% | 20.20M 15.69% | 23.38M 15.79% | 48.83M 108.84% | 121.38M 148.56% | 74.23M 38.84% | 185.57M 149.99% | 16.72M 90.99% | 66.80M 299.57% | |
net cash provided by operating activities | 108.66M - | 111.53M 2.65% | -43.17M 138.71% | -43.97M 1.85% | -48.52M 10.33% | 52.07M 207.33% | 456.94M 777.49% | 890.65M 94.91% | 1.04B 17.27% | -265.87M 125.46% | |
investments in property plant and equipment | -39.41M - | -25.13M 36.25% | -9.71M 61.36% | -34.99M 260.42% | -82.44M 135.62% | -130.84M 58.70% | -401.17M 206.62% | -142.13M 64.57% | -888.02M 524.77% | -1.88B 111.26% | |
acquisitions net | 50K - | 155K 210% | 684K - | 316K 53.80% | |||||||
purchases of investments | -2.95M - | -32.85M 1,014.69% | -77.74M - | -7.77M 90.01% | |||||||
sales maturities of investments | 2.90M - | 32.70M 1,028.58% | 51.50M 57.51% | 77.06M 49.63% | -316K 100.41% | ||||||
other investing activites | 11.63M - | 1.19M 89.81% | 4.57M 285.99% | 1.77M 61.32% | -5.92M 434.48% | 893K 115.09% | -23.27M 2,705.82% | 5.57M 123.93% | -71.36M 1,381.61% | -23.49M 67.08% | |
net cash used for investing activites | -27.78M - | -23.94M 13.82% | -5.13M 78.55% | -33.22M 547.08% | -88.36M 165.98% | -129.94M 47.06% | -424.44M 226.63% | -85.07M 79.96% | -959.38M 1,027.76% | -1.91B 98.80% | |
debt repayment | -35.52M - | -33.85M 4.70% | -38.39M 13.43% | -8.88M 76.87% | -20.00M 125.19% | -66.17M 230.85% | -126.40M 91.04% | -767.79M 507.41% | -60.77M 92.08% | -2.50B 4,015.05% | |
common stock issued | |||||||||||
common stock repurchased | |||||||||||
dividends paid | -3.87M - | -3.87M 0% | -3.87M 0% | -3.87M 0% | -3.88M 0.21% | -3.88M 0.03% | -4.88M 25.81% | -3.63M 25.56% | -9.21M 153.82% | -10.44M 13.31% | |
other financing activites | -28.86M - | -13.23M 54.16% | 90.09M 780.98% | 83.61M 7.19% | 168.74M 101.81% | 147.13M 12.80% | 104.00M 29.32% | -14.76M 114.19% | 38.99M 364.13% | 4.85B 12,351.10% | |
net cash used provided by financing activities | -68.24M - | -50.95M 25.35% | 47.83M 193.89% | 70.86M 48.15% | 144.86M 104.43% | 77.09M 46.78% | -27.28M 135.38% | -786.18M 2,782.31% | -31.00M 96.06% | 2.34B 7,658.80% | |
effect of forex changes on cash | 1K - | -1K - | 1K 200% | 774K 77,300% | 1K 99.87% | -1K 200% | |||||
net change in cash | 12.63M - | 36.65M 190.12% | -475K 101.30% | -6.33M 1,232.63% | 7.99M 226.15% | -777K 109.73% | 5.22M 772.20% | 19.40M 271.43% | 54.07M 178.70% | 169.94M 214.31% | |
cash at beginning of period | 12.78M - | 25.41M 98.83% | 62.06M 144.21% | 61.59M 0.77% | 28.73M 53.36% | 37.39M 30.16% | 36.62M 2.08% | 42.61M 16.38% | 62.01M 45.52% | 116.08M 87.18% | |
cash at end of period | 25.41M - | 62.06M 144.21% | 61.59M 0.76% | 55.26M 10.28% | 36.71M 33.56% | 36.62M 0.26% | 41.84M 14.26% | 62.01M 48.22% | 116.08M 87.19% | 286.02M 146.40% | |
operating cash flow | 108.66M - | 111.53M 2.65% | -43.17M 138.71% | -43.97M 1.85% | -48.52M 10.33% | 52.07M 207.33% | 456.94M 777.49% | 890.65M 94.91% | 1.04B 17.27% | -265.87M 125.46% | |
capital expenditure | -39.41M - | -25.13M 36.25% | -9.71M 61.36% | -34.99M 260.42% | -82.44M 135.62% | -130.84M 58.70% | -401.17M 206.62% | -142.13M 64.57% | -888.02M 524.77% | -1.88B 111.26% | |
free cash flow | 69.25M - | 86.41M 24.78% | -52.88M 161.20% | -78.96M 49.32% | -130.96M 65.85% | -78.76M 39.86% | 55.77M 170.81% | 748.51M 1,242.12% | 156.43M 79.10% | -2.14B 1,469.27% |
All numbers in INR (except ratios and percentages)